March 29 (Reuters) - Johnson & Johnson (NYSE:JNJ) JNJ.N :
* JOHNSON & JOHNSON ANNOUNCES ADVANCE PURCHASE AGREEMENT WITH THE AFRICAN VACCINE ACQUISITION TRUST FOR THE COMPANY'S COVID-19 VACCINE CANDIDATE
* UP TO 400 MILLION DOSES OF COMPANY'S SINGLE-SHOT VACCINE CANDIDATE WILL BE MADE AVAILABLE TO AFRICAN UNION MEMBER STATES
* AVAILABILITY OF VACCINE IS SUBJECT TO NATIONAL REGULATORY APPROVALS
* JANSSEN PHARMACEUTICA AGREED WITH AFRICAN VACCINE ACQUISITION TRUST (AVAT) TO MAKE AVAILABLE UP TO 220 MILLION DOSES OF ITS SINGLE-SHOT COVID-19 VACCINE
* JANSSEN PHARMACEUTICA VACCINE WILL BE AVAILABLE TO AFRICAN UNION'S 55 MEMBER STATES WITH DELIVERY BEGINNING IN Q3 OF 2021